ENXTPA:ERFLife Sciences
Eurofins Scientific ENXTPA ERF Margin Improvement Challenges Longstanding Bearish Earnings Narratives
Eurofins Scientific (ENXTPA:ERF) has reported its FY 2025 results with second half revenue of €3.7b and basic EPS of €1.11, alongside net income of €197.3m, while the trailing 12 months show revenue of €7.3b, EPS of €2.31 and net income of €416m. The company has seen revenue move from €3.5b and EPS of €0.86 in the second half of 2024 to €3.6b and EPS of €1.20 in the first half of 2025, before landing at the latest second half figures. This sets up a story where improving net profit margins...